Value in HealthVolume 18, Issue 7, November 2015, Page A424PSS50 - A Cost-Effectiveness Analysis of Secukinumab 300 Mg Vs Current Therapies for The Treatment of Moderate to Severe Plaque Psoriasis In ItalyAuthor links open overlay panelD’Ausilio A 1, Aiello A 1, Daniel F 1, Graham C 2, Roccia A 3, Toumi M 4Show moreShareCitehttps://doi.org/10.1016/j.jval.2015.09.574Get rights and contentUnder an Elsevier user licenseopen archivePrevious article in issueNext article in issueRecommended articlesCited by (0)Copyright © 2015 Published by Elsevier Inc.